Aviva Industries Limited announced the successful allotment of 80,60,000 equity shares through the conversion of fully convertible equity warrants, marking a significant expansion in the company's equity base. The Board of Directors approved this allotment during their meeting held on January 20, 2026, pursuant to SEBI regulations.

Warrant Conversion Details

The company converted 80,60,000 fully convertible equity warrants at an issue price of ₹28.00 per warrant. These warrants were initially allotted to five non-promoter category investors on a preferential basis between January 6-17, 2026. Each equity share carries a face value of ₹10.00.

The warrant allotment schedule was structured across multiple dates:

Equity Share Distribution

The conversion resulted in equity share allotment across five non-promoter investors. The distribution shows relatively balanced allocation among the recipients:

Capital Structure Impact

The warrant conversion has substantially increased Aviva Industries' paid-up equity share capital. The company's capital structure transformation reflects significant growth in its equity base:

Regulatory Compliance

The allotment was conducted in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting, which commenced at 5:10 PM and concluded at 5:50 PM on January 20, 2026, formally approved the conversion process. The company has informed the Bombay Stock Exchange about this development, maintaining transparency with stakeholders and regulatory compliance.

Aviva Industries Limited has completed the allotment of 48.40 lakh fully convertible equity warrants to three non-promoter investors on January 13, 2026, marking the fourth tranche of its preferential issue program. The board meeting, held at the company's registered office, approved the allotment at an issue price of ₹28.00 per warrant, including a premium of ₹18.00 per warrant.

Warrant Allotment Details

The company allotted warrants to three non-promoter category investors following the special resolution passed by members in the Annual General Meeting on September 30, 2025, and subsequent in-principle approval from BSE on January 02, 2026.

Allottee Distribution

The warrants were distributed among three individual investors, all classified under the non-promoter category:

*Calculated assuming full exercise of warrants and consequent allotment of equity shares.

Conversion Terms and Payment Structure

The fully convertible equity warrants carry specific terms for conversion into equity shares. Each warrant is convertible into one fully paid-up equity share with a face value of ₹10.00 each. The conversion option must be exercised within a maximum period of 18 months from the allotment date.

The payment structure follows SEBI regulations, with allottees required to pay 25% of the consideration amount upfront along with the application. The company has confirmed receipt of this initial payment from all proposed allottees. The remaining 75% becomes payable when allottees exercise their conversion option.

Regulatory Compliance

The allotment was conducted in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and Chapter V of SEBI (ICDR) Regulation 2018. The company has fulfilled all disclosure requirements under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The board meeting commenced at 6:00 PM and concluded at 6:30 PM on January 13, 2026. Currently, there is no change in the paid-up share capital of the company as the warrants have been allotted but not yet converted into equity shares. The number of equity shares to be allotted upon warrant exercise will be subject to appropriate adjustments as permitted under applicable rules, regulations, and laws.